HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rogier M Bertina Selected Research

Tyr sulfate(1)- enkephalinamide-Leu (LETS)

6/2007Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
6/2006Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis.
10/2002Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rogier M Bertina Research Topics

Disease

20Venous Thrombosis (Deep-Vein Thrombosis)
08/2014 - 08/2002
9Venous Thromboembolism
06/2013 - 09/2003
8Thrombosis (Thrombus)
01/2016 - 06/2003
5Thrombophilia
06/2007 - 10/2002
4Activated Protein C Resistance (APC Resistance)
08/2014 - 03/2002
2Myocardial Infarction
03/2009 - 09/2008
2Hemolysis
04/2008 - 01/2004
2Pre-Eclampsia (Preeclampsia)
04/2008 - 01/2004
2HELLP Syndrome
04/2008 - 01/2004
2von Willebrand Diseases (von Willebrand's Disease)
12/2006 - 02/2002
1Disease Progression
01/2016
1Embolism (Embolus)
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2016
1Sepsis (Septicemia)
05/2014
1Bacteremia
05/2014
1Infections
05/2014
1Urinary Tract Infections (Urinary Tract Infection)
05/2014
1Testicular Neoplasms (Testicular Cancer)
02/2013
1Neoplasms (Cancer)
04/2012
1Multiple Myeloma
01/2011
1Vasculitis (Vasculitides)
12/2010
1Necrosis
12/2010
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
12/2010
1Nephrogenic Diabetes Insipidus
06/2010
1Hemorrhage
01/2009
1Stroke (Strokes)
03/2008
1Ischemic Stroke
03/2008
1Type 3 von Willebrand Disease
12/2006
1Acute-Phase Reaction
09/2006
1Pulmonary Embolism
09/2003

Drug/Important Bio-Agent (IBA)

6Thromboplastin (Tissue Factor)IBA
01/2016 - 06/2003
6Factor VIII (Coagulation Factor VIII)IBA
06/2010 - 02/2002
5Fibrinogen (Factor I)FDA Link
08/2014 - 09/2003
5Protein CIBA
08/2014 - 08/2003
4factor V LeidenIBA
08/2014 - 08/2003
4Endothelial Protein C ReceptorIBA
03/2012 - 08/2005
4ThrombinFDA Link
01/2009 - 03/2002
3von Willebrand FactorIBA
06/2010 - 12/2006
3fibrinogen gamma'IBA
06/2009 - 12/2005
3Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA
06/2007 - 10/2002
3AntigensIBA
04/2007 - 10/2002
2AnticoagulantsIBA
01/2016 - 01/2009
2Prothrombin (Factor II)IBA
06/2008 - 09/2003
2EnzymesIBA
04/2008 - 01/2004
2Blood Coagulation Factors (Coagulation Factor)IBA
04/2007 - 09/2003
1Peptides (Polypeptides)IBA
08/2014
1Factor V (Coagulation Factor V)IBA
08/2014
1Anti-Bacterial Agents (Antibiotics)IBA
05/2014
1ThrombomodulinIBA
06/2013
1factor IX-PaduaIBA
12/2011
1PlasminogenIBA
12/2010
1AntibodiesIBA
12/2010
1Interleukin-1 (Interleukin 1)IBA
03/2009
1Messenger RNA (mRNA)IBA
03/2009
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
03/2009
1FibrinIBA
01/2009
1Hemostatics (Antihemorrhagics)IBA
01/2009
1Aquaporin 2IBA
06/2008
1Interleukin-6 (Interleukin 6)IBA
04/2008
1EndotoxinsIBA
04/2008
1NucleotidesIBA
04/2008
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2008
1Cystine (L-Cystine)IBA
12/2006
1DisulfidesIBA
12/2006
1Acute-Phase Proteins (Acute-Phase Protein)IBA
09/2006
1Peptide Hydrolases (Proteases)FDA Link
06/2005
1Factor VII (Proconvertin)IBA
06/2005
1factor V CambridgeIBA
02/2004
1G-protein beta3 subunitIBA
01/2004
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
09/2003
1Factor XI (Plasma Thromboplastin Antecedent)IBA
09/2003
1Factor XIIIaIBA
09/2003
1Oral ContraceptivesIBA
08/2003
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
06/2003
1Factor XIII (Coagulation Factor XIII)IBA
10/2002
1Protein C InhibitorIBA
08/2002

Therapy/Procedure

1Therapeutics
01/2016
1Drug Therapy (Chemotherapy)
02/2013